| Literature DB >> 36117715 |
Chiyuan Zhang1,2, Hui Bai1, Yanfeng Zhang1, Zhengyu Deng1, Lei Zhang1, Xuliang Chen1, Zuli Fu3, Ruizheng Shi3, Guogang Zhang2, Qian Xu1, Guoqiang Lin1.
Abstract
Objective: Oxygenation impairment is a common complication of acute aortic syndrome (AAS) patients after surgical repair. The aim of this study is to identify the relationship between body mass index (BMI) and the risk of postoperative oxygenation impairment in AAS patients.Entities:
Keywords: acute aortic syndrome; body mass index; obesity; overweight; postoperative oxygenation impairment
Year: 2022 PMID: 36117715 PMCID: PMC9470752 DOI: 10.3389/fphys.2022.955702
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
The preoperative characteristics of patients with AAS.
| Non-oxygenation impairment (n = 118) | Oxygenation impairment (n = 109) | Or (95% CI) |
| |
|---|---|---|---|---|
| Age (years) | 53.00 (43.00–62.00) | 52.00 (43.00–59.00) | 1.00 (0.98–1.02) | 0.629 |
| Sex, male (%) | 85 (72.0) | 92 (84.4) | 2.10 (1.09–4.05) | 0.026 |
| BMI (kg/m2) | 23.88 ± 3.23 | 26.08 ± 3.15 | 1.24 (1.13–1.36) | <0.001 |
| BMI (%) | ||||
| 18.5 ≤ BMI<23 (n = 73) | 53 (44.9) | 20 (18.3) | References | — |
| 23 ≤ BMI<25, (n = 42) | 23 (19.5) | 19 (17.4) | 2.19 (0.99–4.85) | 0.054 |
| BMI ≥25, (n = 112) | 42 (35.6) | 70 (64.2) | 4.42 (2.33–8.39) | <0.001 |
| Current smoking, n (%) | 59 (50.0) | 59 (54.1) | 1.18 (0.70–1.99) | 0.534 |
| Time from symptom onset to surgery (h) | 25.39 (13.05–79.48) | 20.67 (10.00–41.64) | 1.00 (1.00–1.00) | 0.308 |
| Medical history | ||||
| Hypertension, n (%) | 76 (64.4) | 84 (77.1) | 1.86 (1.04–3.33) | 0.038 |
| CAD, n (%) | 12 (10.2) | 8 (7.3) | 0.70 (0.28–1.78) | 0.454 |
| Hyperlipemia, n (%) | 5 (4.2) | 3 (2.8) | 0.64 (0.15–2.74) | 0.547 |
| Diabetes mellitus, n (%) | 3 (2.5) | 1 (0.9) | 0.36 (0.04–3.46) | 0.373 |
| Fatty liver, n (%) | 27 (31.0) | 37 (46.3) | 1.91 (1.02–3.60) | 0.044 |
| Marfan syndrome, n (%) | 2 (1.7) | 1 (0.9) | 0.54 (0.05–6.01) | 0.614 |
| COPD, n (%) | 2 (1.7) | 2 (1.8) | 1.08 (0.15–7.83) | 0.936 |
| Chronic liver disease, n (%) | 3 (2.5) | 6 (5.5) | 2.23 (0.55–9.16) | 0.265 |
| Chronic kidney disease, n (%) | 5 (4.2) | 1 (0.9) | 0.21 (0.02–1.82) | 0.156 |
| Preoperative oxygenation impairment, n (%) | 29 (24.6) | 31 (28.4) | 1.22 (0.68–2.20) | 0.510 |
| Vital signs on admission | ||||
| Respiratory rate (/min) | 20.00 (20.00–20.00) | 20.00 (18.00–20.00) | 1.02 (0.90–1.15) | 0.768 |
| SBP (mmHg) | 140.32 ± 27.71 | 144.83 ± 33.60 | 1.01 (1.00–1.01) | 0.270 |
| DBP (mmHg) | 69.00 (62.00–79.00) | 74.00 (64.00–86.00) | 1.01 (1.00–1.03) | 0.082 |
| Heart rate (/min) | 74.00 (65.00–88.00) | 82.00 (70.00–96.50) | 1.02 (1.01–1.04) | 0.010 |
| Preoperative laboratory data | ||||
| Hb (g/L) | 127.50 (113.00–136.00) | 133.00 (122.50–145.00) | 1.02 (1.01–1.04) | 0.004 |
| WBC (×109/L) | 9.85 (6.80–13.30) | 11.10 (8.35–14.25) | 1.03 (0.98–1.09) | 0.279 |
| PLT (×109/L) | 174.00 (135.50–241.25) | 172.00 (118.00–212.50) | 1.00 (0.99–1.00) | 0.158 |
| D-dimer (μg/ml) | 1.52 (0.62–2.67) | 1.40 (0.61–2.74) | 0.98 (0.91–1.06) | 0.624 |
| FDP (mg/L) | 15.50 (5.95–32.83) | 13.55 (6.95–29.30) | 1.00 (0.99–1.01) | 0.704 |
| Cr (μmol/L) | 88.05 (72.58–108,30) | 96.40 (82.55–116.15) | 1.00 (1.00–1.00) | 0.402 |
| CRP (mg/L) | 51.25 (7.39–90.08) | 35.20 (9.15–107.70) | 1.00 (0.99–1.01) | 0.992 |
| Preoperative ultrasound and CT findings | ||||
| Stanford classification | ||||
| Type A, n (%) | 79 (67.5) | 78 (71.6) | References | — |
| Type B, n (%) | 38 (32.5) | 31 (28.4) | 0.83 (0.47–1.46) | 0.510 |
| Aortic dissection, n (%) | 97 (87.4) | 105 (98.1) | 7.58 (1.68–34.20) | 0.008 |
| Intramural hematoma, n (%) | 21 (17.8) | 14 (13.1) | 0.65 (0.31–1.35) | 0.243 |
| LVEDD (mm) | 50.00 (45.00–55.00) | 51.00 (47.00–54.00) | 1.00 (0.96–1.04) | 0.901 |
| LVEF (%) | 60.00 (56.00–66.00) | 60.00 (56.00–65.00) | 0.98 (0.95–1.02) | 0.337 |
| Aortic regurgitation, n (%) | 92 (84.4) | 84 (84.8) | 1.04 (0.49–2.20) | 0.929 |
| Pleural effusion, n (%) | 39 (40.2) | 40 (43.5) | 1.14 (0.64–2.04) | 0.649 |
| Medications on admission | ||||
| Vasodilators, n (%) | 73 (61.9) | 80 (73.4) | 1.70 (0.97–3.00) | 0.065 |
Data are presented as mean ± SD, n (%), or medians (interquartile ranges). p values for univariate logistic regression. AAS, acute aortic syndrome; OR, odds ratio; CI, confidence interval; BMI, body mass index; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; SBP, systolic blood pressure; DBP, diastolic blood pressure; WBC, white blood cell; Hb, hemoglobin; PLT, platelet; FDP, fibrinogen degradation products; Cr, creatinine; CRP, C reactive protein; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction.
The intraoperative and postoperative characteristics of patients with AAS.
| Non-oxygenation impairment (n = 118) | Oxygenation impairment (n = 109) | OR (95% CI) |
| |
|---|---|---|---|---|
| Intraoperative data | ||||
| Aortic root replacement, n (%) | 65 (55.1) | 69 (63.3) | 1.41 (0.83–2.40) | 0.209 |
| Hemiarch replacement, n (%) | 9 (7.6) | 10 (9.2) | 1.22 (0.48–3.13) | 0.674 |
| Total arch replacement, n (%) | 61 (51.7) | 67 (61.5) | 1.49 (0.88–2.53) | 0.139 |
| Stented elephant trunk, n (%) | 58 (49.2) | 64 (58.7) | 1.47 (0.87–2.49) | 0.149 |
| Bentall operation, n (%) | 23 (19.5) | 14 (12.8) | 0.61 (0.30–1.25) | 0.178 |
| David operation, n (%) | 2 (1.7) | 0 (0.0) | — | — |
| TEVAR, n (%) | 34 (28.8) | 26 (23.9) | 0.77 (0.43–1.40) | 0.398 |
| CABG operation, n (%) | 6 (5.1) | 3 (2.8) | 0.53 (0.13–2.17) | 0.375 |
| CPB time (h) | 3.43 (2.82–4.07) | 3.43 (2.77–4.39) | 1.04 (0.87–1.24) | 0.694 |
| Cross-clamp time (h) | 1.64 (1.22–2.44) | 1.52 (1.21–2.08) | 0.95 (0.71–1.28) | 0.751 |
| Circulatory arrest time (min) | 30.00 (21.00–36.00) | 30.00 (22.00–40.00) | 1.00 (0.98–1.01) | 0.538 |
| Operation time (h) | 6.33 (2.04–7.69) | 6.75 (4.92–8.42) | 1.07 (0.99–1.15) | 0.082 |
| Nasopharyngeal temperature (°C) | 25.20 (24.35–26.50) | 25.00 (24.30–27.00) | 0.98 (0.89–1.07) | 0.604 |
| RBC transfusion (u) | 4.00 (2.00–6.00) | 4.00 (2.00–5.50) | 1.01 (0.95–1.09) | 0.680 |
| PLT transfusion (u) | 1.00 (1.00–2.00) | 1.00 (1.00–2.00) | 1.00 (0.99–1.01) | 0.703 |
| Plasma transfusion (ml) | 550.00 (350.00–650.00) | 500.00 (380.00–600.00) | 1.00 (1.00–1.00) | 0.755 |
| Postoperative data | ||||
| CRP (mg/L) | 136.00 (85.05–176.25) | 124.29 (78.20–199.00) | 1.00 (1.00–1.00) | 0.885 |
| Mechanical ventilation time (h) | 37.40 (16.47–81.22) | 89.61 (36.45–138.38) | 1.01 (1.00–1.01) | 0.032 |
| Tracheotomy, n (%) | 113 (95.8) | 109 (100.0) | 4.78 (0.55–41.57) | 0.156 |
| Pneumonia, n (%) | 71 (60.2) | 80 (73.4) | 1.83 (1.04–3.21) | 0.036 |
| Cerebral infarction, n (%) | 5 (4.2) | 6 (5.5) | 1.32 (0.39–4.44) | 0.658 |
| Delirium, n (%) | 39 (33.1) | 44 (40.4) | 1.37 (0.80–2.36) | 0.253 |
| AKI, n (%) | 9 (7.6) | 19 (17.4) | 2.56 (1.10–5.93) | 0.029 |
| Renal replacement therapy, n (%) | 6 (5.1) | 8 (7.3) | 1.48 (0.50–4.41) | 0.483 |
| ICU stay (days) | 5.00 (3.75–8.00) | 6.00 (4.00–9.00) | 1.01 (0.96–1.05) | 0.762 |
| Hospital stay (days) | 12.00 (9.00–18.00) | 13.00 (9.50–18.00) | 1.00 (0.97–1.03) | 0.913 |
| In hospital death, n (%) | 7 (5.9) | 12 (11.0) | 1.96 (0.74–5.18) | 0.174 |
Data are presented as mean ± SD, n (%), or medians (interquartile ranges). p values for univariate logistic regression. AAS, acute aortic syndrome; OR, odds ratio; CI, confidence interval; TEVAR, thoracic endovascular aortic repair; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; RBC, red blood cell; PLT, platelet; CRP, C reactive protein; AKI, acute kidney injury; ICU, intensive care unit.
Multivariate logistic regression analysis for AAS with postoperative oxygenation impairment.
| OR (95% CI) |
| |
|---|---|---|
| Sex, male (%) | 1.14 (0.41–3.16) | 0.809 |
| BMI (kg/m2) | 1.27 (1.10–1.46) | 0.00 |
| BMI (n, %) | ||
| 18.5 ≤ BMI< 23 | References | — |
| 23 ≤ BMI <25 | 4.96 (1.62–15.15) | 0.005 |
| BMI ≥25 | 9.51 (3.06–29.57) | <0.001 |
| Hypertension, n (%) | 0.63 (0.27–1.44) | 0.271 |
| Hyperlipemia, n (%) | 0.18 (0.03–1.35) | 0.096 |
| Diabetes mellitus, n (%) | 0.56 (0.02–15.44) | 0.730 |
| Fatty liver, n (%) | 1.18 (0.48–2.88) | 0.725 |
| Preoperative oxygenation impairment, n (%) | 0.52 (0.22–1.28) | 0.155 |
| Heart rate (/min) | 1.01 (0.99–1.03) | 0.475 |
| Hb (g/L) | 1.02 (1.00–1.04) | 0.055 |
| Aortic dissection, n (%) | 11.62 (1.07–126.55) | 0.052 |
| Mechanical ventilation time (h) | 1.00 (1.00–1.00) | 0.605 |
| Pneumonia, n (%) | 1.54 (0.68–3.47) | 0.302 |
| AKI, n (%) | 2.13 (0.69–6.56) | 0.187 |
Adjusted to sex, hypertension, fatty liver, hyperlipemia, diabetes mellitus, heart rate, Hb, preoperative oxygenation impairment, aortic dissection, mechanical ventilation time, pneumonia and AKI. AAS, acute aortic syndrome; OR, odds ratio; CI, confidence interval; BMI, body mass index; Hb, hemoglobin; AKI, acute kidney injury.
FIGURE 1The dose-response relationship analysis of BMI and AAS with postoperative oxygenation impairment. The solid red line and the dashed-blue line represent the estimated OR and 95% CI, respectively. BMI, body mass index; AAS, acute aortic syndrome; OR, odds ratio; CI, confidence interval.
Subgroup analysis and interaction analysis of the relationship between BMI and AAS with postoperative oxygenation impairment.
| No. of patients | BMI levels (kg/m2) |
| |||
|---|---|---|---|---|---|
| <23 | 23–25 | ≥25 | |||
| Sex | 0.482 | ||||
| Male | 177 | ref | 3.86 (1.51–9.86) | 4.30 (1.96–9.44) | |
| Female | 50 | ref | 1.50 (0.22–10.36) | 2.00 (0.55–7.24) | |
| Age, years | 0.500 | ||||
| <60 | 165 | ref | 4.63 (1.72–12.47) | 4.63 (1.99–10.75) | |
| ≥60 | 62 | ref | 1.43 (0.27–7.44) | 2.56 (0.84–7.83) | |
| Stanford classification | 0.743 | ||||
| Type A | 157 | ref | 3.96 (1.46–10.75) | 3.68 (1.68–8.06) | |
| Type B | 69 | ref | 2.40 (0.57–10.04) | 3.84 (1.14–12.95) | |
| AD | 0.539 | ||||
| No | 16 | ref | — | 3.33 (0.36–30.70) | |
| Yes | 202 | ref | 3.39 (1.43–8.05) | 4.12 (2.02–8.39) | |
| IMH | 0.326 | ||||
| No | 183 | ref | 3.30 (1.32–8.27) | 4.59 (2.15–9.79) | |
| Yes | 35 | ref | 8.75 (0.74–103.82) | 2.19 (0.47–10.21) | |
| Current smoking | 0.198 | ||||
| No | 109 | ref | 2.45 (0.84–7.21) | 2.05 (0.85–4.90) | |
| Yes | 118 | ref | 6.14 (1.58–23.79) | 8.61 (2.71–27.39) | |
| Current drinking | 0.274 | ||||
| No | 171 | ref | 4.48 (1.76–11.43) | 3.52 (1.68–7.38) | |
| Yes | 56 | ref | 1.33 (0.22–7.98) | 3.62 (0.81–16.15) | |
| Fatty liver | 0.500 | ||||
| No | 103 | ref | 3.90 (1.34–11.34) | 4.80 (1.70–13.59) | |
| Yes | 64 | ref | 15.00 (1.03–218.30) | 6.91 (0.75–63.53) | |
| Hypertension | 0.884 | ||||
| No | 67 | ref | 2.25 (0.44–11.48) | 3.41 (1.07–10.86) | |
| Yes | 160 | ref | 3.25 (1.18–8.96) | 3.37 (1.42–7.99) | |
| CAD | 0.533 | ||||
| No | 207 | ref | 3.10 (1.34–7.14) | 3.25 (1.65–6.38) | |
| Yes | 20 | ref | — | — | |
| Diabetes | 0.564 | ||||
| No | 223 | ref | 3.24 (1.42–7.38) | 3.54 (1.83–6.85) | |
| Yes | 4 | ref | — | — | |
| COPD | 0.261 | ||||
| No | 223 | ref | 3.61 (1.58–8.26) | 3.90 (2.00–7.62) | |
| Yes | 4 | ref | — | — | |
| SBP, mmHg | 0.057 | ||||
| <140 | 104 | ref | 4.14 (1.35–12.66) | 2.07 (0.83–5.17) | |
| ≥140 | 123 | ref | 2.69 (0.76–9.59) | 6.55 (2.41–17.83) | |
| DBP, mmHg | 0.658 | ||||
| <90 | 192 | ref | 3.77 (1.57–9.05) | 3.65 (1.78–7.51) | |
| ≥90 | 35 | ref | 1.33 (0.14–12.82) | 3.25 (0.63–16.79) | |
| Preoperative WBC, 109/L | 0.209 | ||||
| <9.5 | 93 | ref | 1.89 (0.59–6.07) | 1.89 (0.72–5.00) | |
| ≥9.5 | 134 | ref | 5.57 (1.74–17.86) | 5.95 (2.31–15.27) | |
| Preoperative D-dimer, μg/mL | 0.385 | ||||
| <0.5 | 42 | ref | 1.14 (0.15–8.59) | 2.55 (0.52–12.37) | |
| ≥0.5 | 184 | ref | 4.27 (1.71–10.66) | 3.99 (1.93–8.25) | |
| Preoperative FDP, mg/L | 0.904 | ||||
| <5 | 36 | ref | 3.00 (0.42–21.30) | 3.00 (0.58–15.61) | |
| ≥5 | 184 | ref | 3.50 (1.41–8.68)_ | 4.02 (1.91–8.44) | |
| Preoperative Cr, μmol/L | 0.349 | ||||
| <111 | 168 | ref | 2.54 (0.96–6.70) | 4.01 (1.89–8.52) | |
| ≥111 | 59 | ref | 5.40 (1.12–26.04) | 2.80 (0.73–10.76) | |
| Preoperative PaO2/FiO2 ratio | 0.592 | ||||
| ≤200 | 60 | ref | 2.46 (1.27–6.63) | 5.32 (1.75–8.74) | |
| >200 | 167 | ref | 2.19 (0.95–5.06) | 4.78 (2.28–10.02) | |
| Preoperative ESR, mm/h | 0.616 | ||||
| <20 | 65 | ref | 7.71 (1.25–47.75) | 4.91 (1.57–15.31) | |
| ≥20 | 80 | ref | 3.21 (0.83–12.47) | 3.12 (1.03–9.46) | |
| Preoperative CRP, mg/l | 0.272 | ||||
| <8 | 23 | ref | 1.13 (0.08–16.31) | 1.69 (0.25–11.34) | |
| ≥8 | 70 | ref | 12.80 (2.02–81.12) | 10.35 (2.09–51.30) | |
| Preoperative IL-1β, pg/ml | 0.672 | ||||
| <5.0 | 43 | ref | 2.89 (0.33–25.70) | 3.00 (0.66–13.66) | |
| ≥5.0 | 50 | ref | 4.50 (0.82–24.57) | 6.00 (1.46–24.69) | |
| Preoperative TNF-α, pg/ml | 0.788 | ||||
| <8.1 | 34 | ref | 4.67 (0.53–40.89) | 2.80 (0.45–17.38) | |
| ≥8.1 | 49 | ref | 4.53 (0.75–27.39) | 5.10 (1.34–19.47) | |
| Preoperative IL-6, pg/ml | 0.078 | ||||
| <5.0 | 3 | ref | — | — | |
| ≥5.0 | 90 | ref | 3.57 (0.93–13.66) | 4.70 (1.68–13.15) | |
| Preoperative IL-10, pg/ml | 0.763 | ||||
| <9.1 | 58 | ref | 5.63 (1.02–30.90) | 4.18 (1.12–15.65) | |
| ≥9.1 | 34 | ref | 2.00 (0.24–16.61) | 3.43 (0.65–18.22) | |
| Aortic regurgitation | 0.349 | ||||
| No | 32 | ref | 6.00 (0.58–61.82) | 5.20 (0.71–37.90) | |
| Yes | 176 | ref | 1.02 (0.42–2.48) | 1.77 (0.90–3.44) | |
| Pleural effusion | 0.373 | ||||
| No | 110 | ref | 2.92 (0.83–10.27) | 4.33 (1.69–11.08) | |
| Yes | 79 | ref | 3.82 (1.05–13.91) | 2.06 (0.69–6.15) | |
| Postoperative ESR, mm/h | 0.511 | ||||
| <20 | 15 | ref | 2.50 (0.10–62.51) | 1.25 (0.12–13.24) | |
| ≥20 | 69 | ref | 6.25 (1.15–34.12) | 6.25 (1.78–22.01) | |
| Postoperative CRP, mg/l | — | ||||
| <8 | 1 | ref | — | — | |
| ≥8 | 77 | ref | 5.25 (1.13–24.42) | 4.09 (1.18–14.15) | |
| Postoperative IL-1β, pg/ml | 0.072 | ||||
| <5.0 | 33 | ref | 1.00 (0.13–8.00) | 1.33 (0.27–6.50) | |
| ≥5.0 | 37 | ref | — | 6.67 (1.16–38.25) | |
| Postoperative TNF-α, pg/ml | 0.027 | ||||
| <8.1 | 14 | ref | 0.67 (0.03–18.06) | 0.11 (0.01–1.78) | |
| ≥8.1 | 50 | ref | 12.50 (1.60–97.65) | 6.36 (1.46–27.67) | |
| Postoperative IL-6, pg/ml | — | ||||
| <5.0 | 0 | ref | — | — | |
| ≥5.0 | 70 | ref | 4.50 (0.94–21.56) | 3.00 (0.97–9.30) | |
| Postoperative IL-10, pg/ml | 0.658 | ||||
| <5.9 | 14 | ref | 6.00 (0.22–162.53) | 1.50 (0.09–25.39) | |
| ≥5.9 | 56 | ref | 3.20 (0.48–21.17) | 3.43 (0.99–11.85) | |
BMI, body mass index; AAS, acute aortic syndrome; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; AD, aortic dissection; IMH, intramural hematoma; SBP, systolic blood pressure; DBP, diastolic blood pressure; WBC, white blood cell; FDP, fibrinogen degradation products; Cr, creatinine; ESR, erythrocyte sedimentation rate; CRP, C reactive protein; IL-1β, Interleukin-1β; TNF-α, Tumor necrosis factor-α; IL-6, Interleukin-6; IL-10, Interleukin-10.
FIGURE 2Changes of PaO2/FiO2 ratio in different BMI groups over time during perioperative period. PaO2/FiO2, arterial oxygen tension/inspiratory oxygen fraction; BMI, body mass index.
FIGURE 3Forest plot of OR of BMI and postoperative oxygenation impairment in AAS patients. OR, odds ratio; BMI, body mass index; AAS, acute aortic syndrome.